US Executive Officer Management Changes SEC — June 16, 2026

16-06-2026

Urban One, Inc. entered into a new employment agreement with CFO Peter D. Thompson through January 6, 2029, with a base salary of $750,000 and eligibility for annual bonuses up to $396,000 (132% of $300,000 target) plus a $850,000 completion bonus contingent on remediation of material weaknesses. At the June 11, 2026 annual meeting, all six director nominees were elected, the 2026 Equity and Performance Incentive Plan was approved (3,083,564 for, 41,890 against), and PricewaterhouseCoopers LLP was ratified as auditor (3,336,914 for, 2,541 against). However, the company continues to have material weaknesses in internal controls as of December 31, 2025, which must be remediated for the CFO to receive the completion bonus.

• · CFO Peter Thompson's employment agreement runs through January 6, 2029, with a signing bonus of $333,333 subject to pro-rata claw-back if he leaves before term end.
• · The $850,000 completion bonus for CFO is contingent on remediation of material weaknesses identified in the Form 10-K for the period ended December 31, 2025.
• · Class D common stock grants to CFO: $704,250 for each of contract years ending Jan 6, 2026 and Jan 6, 2027; $469,500 for each of contract years ending Jan 6, 2028 and Jan 6, 2029.
• · Performance grants to CFO: target value $234,750 for 2026-2027; target value $469,500 for 2028-2029.
• · At the annual meeting, 216,776 non-votes were recorded for each director election, representing shares not voted.
• · The 2026 Equity and Performance Incentive Plan received 3,083,564 votes for and 41,890 against, with 217,508 abstentions.
• · Ratification of PricewaterhouseCoopers LLP was nearly unanimous: 3,336,914 for, 2,541 against, 3,507 abstentions.
• · Class C and Class D common stock were not entitled to vote on any proposal at the meeting.

16-06-2026

GeneDx Holdings Corp. announced the appointment of Mark Gardner as President, effective June 15, 2026, reporting to CEO Katherine Stueland. Gardner, formerly Senior Vice President of Molecular Genomics and Oncology at Quest Diagnostics, will lead commercial and operations teams to scale efficiently and strengthen execution. The filing contains no financial data or performance metrics, so no positive or negative trends can be assessed.

• · Mark Gardner previously served as Senior Vice President of Molecular Genomics and Oncology at Quest Diagnostics.
• · He also served as CEO of OmniSeq, a precision medicine company acquired by Labcorp.
• · Gardner held senior leadership roles at Thermo Fisher Scientific and Life Technologies.
• · He began his career as a P-3 Orion pilot in the U.S. Navy, rising to Lieutenant Commander.
• · Gardner holds an MBA from The Wharton School, a master's from Georgetown University, and a bachelor's from the U.S. Naval Academy.
• · GeneDx has diagnosed more than 4,800 genetic diseases and published over 1,100 research publications.
• · GeneDx's ExomeDx and GenomeDx tests have FDA Breakthrough Device designation.

16-06-2026

Encore Capital Group, Inc. filed an 8-K on June 16, 2026, reporting the adoption of a Third Certificate of Amendment to its Certificate of Incorporation, approved by stockholders at the annual meeting. The amendment limits the personal liability of directors and officers for monetary damages for breach of fiduciary duty to the fullest extent permitted by Delaware law. No financial figures or period-over-period comparisons are included in this filing.

• · The amendment changes Article Eight of the Certificate of Incorporation to limit director and officer liability for monetary damages for breach of fiduciary duty.
• · The amendment was approved by stockholders at the annual meeting held on notice in accordance with Section 222 of the Delaware General Corporation Law.
• · The certificate was signed on June 12, 2026, by Secretary Andrew Asch.
• · The corporation was originally incorporated as MCM Capital Group, Inc. on April 29, 1999.

16-06-2026

FreightCar America appointed Bradley J. Pickard as an independent director effective June 10, 2026. The Board now comprises nine directors, six of whom are independent. Chairman James R. Meyer highlighted Mr. Pickard's three decades of corporate finance and capital markets experience, particularly in rail, trucking and logistics, as valuable for the Company's continued platform strengthening, aftermarket expansion and disciplined growth.

• · Mr. Pickard is a Managing Director of Republic Partners, LLC (since 2014).
• · Prior leadership roles at Salomon Brothers, Wasserstein Perella and Houlihan Lokey Howard & Zukin.
• · He holds a BA from the University of Michigan and an MBA from the University of Chicago.
• · Company was founded in 1901 and is headquartered in Chicago, Illinois.

16-06-2026

At Natera, Inc.'s Annual Meeting on June 11, 2026, stockholders elected four directors and ratified Ernst & Young LLP as independent auditor for FY 2026. The advisory vote on executive compensation ('Say-on-Pay') passed with 97.96% support, but a proposal to amend the 2015 Equity Incentive Plan (adding 3.2 million shares) received only 78.1% of votes cast in favor, with significant opposition (26.9 million against). Overall, the meeting showed strong shareholder support for governance decisions but notable dissent on equity compensation expansion.

• · Proposal 5 (equity plan amendment) had 26,861,815 votes against and 123,232 abstentions, reflecting notable shareholder opposition.
• · All director nominees were elected; Eric H. Rubin (Class I) received the highest support (98.3% of votes cast).
• · The advisory vote on frequency of Say-on-Pay favored 'One Year' (121.6 million votes vs. 36,823 for Two Years and 972,982 for Three Years).
• · No broker non-votes were present for Proposal 2 (auditor ratification) because it is considered a routine matter.
• · Record date was April 15, 2026, and 130,691,097 of 142,778,493 outstanding shares were represented at the meeting (91.5% turnout).

16-06-2026

AT&T Inc. announced the retirement of Pascal Desroches as Senior Executive Vice President and CFO, effective December 31, 2026, and the appointment of Jennifer Biry as Deputy CFO starting July 6, 2026, with her assuming the CFO role on January 1, 2027. Ms. Biry has prior AT&T experience, including serving as EVP and CFO of WarnerMedia, but the filing also discloses that her stepdaughter is employed by an AT&T subsidiary earning approximately $141,090 in 2025, creating a related-party interest. The transition appears orderly, with a six-month overlap to ensure continuity.

• · Pascal Desroches' retirement announcement was made on June 11, 2026, and is effective December 31, 2026.
• · Jennifer Biry was appointed Deputy CFO on June 15, 2026, effective July 6, 2026.
• · Ms. Biry will become CFO on January 1, 2027, ensuring a six-month transition period.
• · Ms. Biry served as CFO and COO of McAfee since 2022, and previously held senior finance, sales, and strategy roles at AT&T from 1999 to 2022, including EVP and CFO of WarnerMedia (2020–2022).
• · Ms. Biry's stepdaughter is an AT&T subsidiary employee with approximate 2025 compensation of $141,090, a rate comparable to similar positions at the company.

16-06-2026

On June 15, 2026, Brady Priest notified Clover Health Investments of his decision to step down as CEO of Clover Care Services, effective July 3, 2026. The company will not appoint a successor; instead, his responsibilities will be reorganized and allocated among existing executive leadership to better integrate the home-care business with broader operations. The departure was not due to any disagreement with the company.

• · The company is a remote-first organization and does not maintain a headquarters.
• · Stockholder communications may be directed to secretary@cloverhealth.com or to The Corporation Trust Company in Wilmington, Delaware.
• · The filing includes forward-looking statements regarding the anticipated benefits of the organizational restructuring.

16-06-2026

On June 15, 2026, Century Therapeutics entered into an amended employment agreement with Dr. Chad Cowan, its Chief Scientific Officer, moving him to a part-time role with a reduced annual salary of $296,150 and a pro-rated annual bonus. The change reflects a reduction in executive commitment but does not terminate his position, signaling a potential cost-saving measure while retaining key scientific leadership.

• · Dr. Cowan will continue as CSO on a part-time basis and is eligible for an annual performance-based target bonus on a pro-rated basis.
• · Upon termination or resignation, Dr. Cowan is entitled to all accrued and unpaid base salary through the date of cessation.
• · The A&R Agreement is to be filed as an exhibit to the Company's Quarterly Report on Form 10-Q for the quarter ended June 30, 2026.
• · No new director appointments or other officer changes were reported.

16-06-2026

On June 11, 2026, C3.ai director and special advisor Jim H. Snabe notified the company he would take an immediate leave of absence due to his appointment as Special Envoy to the European Commission for Industrial AI. During the leave, he will have no voting rights or duties on the Board or as CEO advisor, and he will not stand for re-election at the 2026 annual meeting. The Board was reduced from 12 to 11 members effective the following day. Mr. Snabe is expected to return after the leave, the duration of which is undetermined.

• · Jim H. Snabe was serving as a special advisor to CEO Thomas M. Siebel prior to the leave
• · The leave is in connection with Snabe's appointment as Special Envoy to the European Commission for Industrial Artificial Intelligence
• · Snabe will not stand for re-election at the 2026 annual stockholder meeting
• · The Board reduction from 12 to 11 directors took effect on June 12, 2026 (the calendar day after the Effective Date)
• · The duration of the leave of absence has not been determined

16-06-2026

On June 10, 2026, Nicholas J. Etten resigned as a director of CEA Industries Inc., effective in June 2026. The filing does not provide any financial data or performance metrics, so no positive or negative trends can be assessed.

• · The resignation was effective June 10, 2026, with the effective date expected in June 2026.
• · No reason for resignation was disclosed in the filing.
• · The filing includes no financial statements or exhibits beyond the cover page.

16-06-2026

Arrowhead Pharmaceuticals appointed Dr. Matt Cohen, M.D., M.B.A., as a director on June 12, 2026. Dr. Cohen brings over 25 years of healthcare investing and portfolio management experience, including roles at Vida Ventures and JP Morgan Asset Management. He will receive standard non-employee director compensation and a sign-on grant of restricted stock units valued at $887,000 vesting over three years.

• · Dr. Cohen holds an M.B.A. from NYU Stern School of Business and an M.D. from McGill University.
• · He was a lead portfolio manager for the JP Morgan Global Healthcare Fund and co-portfolio manager for the JP Morgan Small Cap Growth Fund.
• · There are no family relationships between Dr. Cohen and any company directors or executive officers.
• · The appointment is effective June 12, 2026.

16-06-2026

VirnetX Holding Corp held its 2026 annual meeting on June 11, 2026, where stockholders approved an amendment to the 2013 Equity Incentive Plan to increase the share reserve by 1,000,000 shares, elected two Class I directors (Kendall Larsen and Gary W. Feiner), ratified Farber Hass Hurley LLP as auditor for FY2026, and approved executive compensation on an advisory basis. However, the equity plan amendment received only 79.8% of votes cast in favor (1,014,822 for vs. 254,814 against), indicating notable shareholder dissent, and broker non-votes were high across all proposals.

• · The equity plan amendment received 254,814 votes against (19.9% of votes cast), indicating significant shareholder opposition.
• · Broker non-votes totaled 1,364,617 on Proposals 1, 3, and 4, representing 51.7% of shares present.
• · Gary W. Feiner received 137,789 votes withheld (10.8% of votes cast for his election), compared to 45,508 for Kendall Larsen.
• · The advisory vote on executive compensation had 93,643 votes against (7.4% of votes cast).
• · Auditor ratification was the most strongly supported proposal with 2,486,962 votes for (94.2% of votes cast).

16-06-2026

American Airlines Group Inc. announced that Vice Chair and Chief Strategy Officer Steve Johnson will retire at the end of 2026, after more than 30 years in the industry. Johnson, who joined America West Airlines in 1995 and later rejoined US Airways in 2009, played a key role in stabilizing the airline's commercial operations, securing a new agreement with Citi, and rebuilding sales and distribution strategy. CEO Robert Isom praised Johnson's contributions, noting he will remain with the company for a few more months before his retirement.

• · Steve Johnson joined America West Airlines in 1995.
• · From 2003 to 2009, he was a partner at Indigo Partners, a private equity firm specializing in airline investments.
• · He rejoined US Airways in 2009.
• · He led the Corporate Affairs organization before being named to his current position.
• · He stepped in to lead the Commercial organization for 18 months during a critical period.

16-06-2026

Dynex Capital appointed Douglas Neal as an independent director to its Board of Directors effective June 15, 2026. Mr. Neal brings extensive investment banking and financial services experience, including over 20 years at BofA Merrill Lynch where he advised on more than $50 billion in transactions, and will serve on the Audit and Compensation Committees. The appointment is expected to support the company's growth and long-term shareholder value, though no specific financial metrics or performance changes were disclosed.

• · Douglas Neal currently manages real estate investments and advises early-stage property technology companies.
• · He served as a Senior Managing Director at BofA Merrill Lynch and was a founding member of the firm's Real Estate Banking Group.
• · He currently serves as an independent board member of Burroughs & Chapin Company, Inc. and as Chairperson of The Boost Pad.
• · Mr. Neal is expected to stand for re-election at the Company's 2027 Annual Meeting of Shareholders.

16-06-2026

Norwegian Cruise Line Holdings Ltd. held its annual general meeting on June 11, 2026, with 79.25% of shares represented. Shareholders approved all six proposals, including the election of three Class I directors, the advisory say-on-pay vote (with 85.8% support), the amendment to the 2013 Performance Incentive Plan (increasing authorized shares by 8,807,000 to 56,816,006 and extending the plan to 2036), ratification of PwC as auditor, and a shareholder proposal to declassify the Board. However, the say-on-pay vote saw 14.2% against, and the shareholder proposal received 12.9% against, indicating notable dissent on governance matters.

• · The Restated 2013 Plan extends the expiration date to February 8, 2036.
• · Shareholders approved the declassification of the Board with 235,818,734 votes for, 35,431,208 against, and 930,076 abstentions.
• · The say-on-pay vote received 233,387,448 for, 38,145,401 against, and 647,169 abstentions.
• · The ratification of PwC as auditor received 353,556,052 for, 9,454,489 against, and 841,954 abstentions.
• · The amendment to the 2013 Plan was approved with 262,009,659 for, 9,510,085 against, and 660,274 abstentions.
• · The frequency of future say-on-pay votes was set to annual (265,317,260 for 1 year, 498,761 for 2 years, 5,418,226 for 3 years, 945,771 abstain).

16-06-2026

Candel Therapeutics, Inc. entered into an employment agreement with CFO Charles Schoch on June 12, 2026, formalizing his continued at-will employment with an annual base salary of $468,600 and a target annual bonus of 40% of base salary. The agreement includes severance provisions of nine months' salary plus target bonus upon qualifying termination, and full acceleration of time-based equity awards upon a qualifying termination within one month before or 12 months after a change in control. No negative or flat metrics are present in this filing.

• · The employment agreement includes customary provisions regarding confidentiality, non-competition, and non-solicitation.
• · Severance eligibility requires execution of a separation agreement and release within 60 days of termination.
• · COBRA premium payments by the company cease upon Mr. Schoch's eligibility for group medical plan benefits under another employer or cessation of COBRA rights.

16-06-2026

HubSpot Inc. held its 2026 Annual Meeting on June 15, 2026, where stockholders approved an amendment to the 2024 Stock Option and Incentive Plan, increasing the reserved shares by 2,300,000, and ratified the appointment of PricewaterhouseCoopers LLP as the independent auditor. All five Class III director nominees were elected, with Yamini Rangan receiving the highest support (37,499,400 votes for) and Claire Hughes Johnson receiving the lowest (34,396,195 votes for). A non-binding stockholder proposal to allow 10% owners to call special meetings was also approved.

• · Approximately 7.1 million broker non-votes were recorded on most proposals.
• · The proposal to ratify PricewaterhouseCoopers LLP passed with 44,385,046 votes for, 603,404 against, and 33,249 abstentions.
• · The non-binding advisory vote on executive compensation received 34,125,774 votes for and 3,704,399 against (plus 84,116 abstentions and 7,107,410 broker non-votes).
• · The stockholder proposal for special shareholder meeting improvement passed with 30,011,042 votes for and 7,866,837 against.
• · The adjournment proposal received 38,290,605 votes for and 6,682,008 against.
• · All directors were elected to one-year terms ending at the 2027 annual meeting.

16-06-2026

Bruce T. Crawford resigned from the Board of Directors of Comtech Telecommunications Corp., effective June 16, 2026, to become president and CEO of AFCEA International. His resignation was not due to any disagreement with the Company or the Board.

• · Mr. Crawford's resignation was previously disclosed in a Form 8-K filed on May 14, 2026.
• · The Company and Board thanked Mr. Crawford for his dedication and years of service.

16-06-2026

Columbia Sportswear held its 2026 Annual Meeting on June 10, 2026, with 97% of outstanding shares voted. Shareholders approved the Amended and Restated 2020 Stock Incentive Plan, increasing authorized shares by 4.5 million to 9 million, and ratified Deloitte & Touche as auditor. However, the proxy access shareholder proposal was rejected by a wide margin (13.9M for vs 34.0M against), and while executive compensation passed, the stock plan approval saw notable opposition with 6.9 million votes against.

• · All 10 director nominees were elected with strong support; the lowest vote total was Andy D. Bryant with 46,397,053 for (1,567,463 against/withheld).
• · Executive compensation (say-on-pay) passed with 47,847,695 for, 98,053 against, and 18,768 abstentions.
• · The proxy access shareholder proposal was rejected with 13,880,262 for, 34,042,003 against, and 42,251 abstentions.
• · The Amended Plan approval saw 41,006,074 for and 6,931,794 against, indicating significant shareholder dissent (about 14.5% of votes cast excluding broker non-votes).
• · Deloitte & Touche LLP was ratified as independent auditor for 2026 with 49,393,337 for, 205,267 against, and 13,996 abstentions.

16-06-2026

Travere Therapeutics announced the planned retirement of Chief Research Officer Dr. William Rote, effective February 17, 2027, with his responsibilities to be assumed by Dr. Jula Inrig, who will become Executive Vice President, Head of Research & Development and Chief Medical Officer as of July 1, 2026. The transition includes a consulting arrangement to retain access to Dr. Rote after his retirement, but no negative performance impacts were mentioned in the filing.

• · Dr. Rote's retirement date is February 17, 2027, marking his 10th employment anniversary with the company.
• · Dr. Inrig is being named Executive Vice President, Head of Research & Development and Chief Medical Officer, effective July 1, 2026.
• · Dr. Rote is expected to continue serving in his current role through the Retirement Date and assist with the transition.
• · The company expects to enter into a consulting arrangement with Dr. Rote following his retirement.

16-06-2026

Organogenesis Holdings Inc. held its 2026 Annual Meeting on June 15, 2026, where all 9 director nominees were elected and stockholders approved, on an advisory basis, executive compensation and the ratification of RSM US LLP as auditor for fiscal 2026. The meeting saw 129,564,421 shares of Class A common stock (including shares issuable upon conversion of Series A Preferred) voted. However, director Glenn H. Nussdorf received the most votes withheld (24,250,579) and the lowest votes for (61,049,018), while the advisory vote on executive compensation had 12,722,258 votes against, indicating notable shareholder dissent on those items.

• · Garrett Lustig was re-elected to the board by Series A Convertible Preferred Stock holders via written consent on June 15, 2026.
• · Director Glenn H. Nussdorf received the lowest support with only 61,049,018 votes for and 24,250,579 votes withheld, representing about 28.4% of shares voted withheld.
• · The advisory vote on executive compensation had 12,722,258 votes against, representing approximately 14.9% of shares voted on that proposal.
• · Ratification of RSM US LLP as auditor passed overwhelmingly with 128,421,160 votes for and only 856,933 against.
• · Broker non-votes totaled 44,264,824 for each director election and the executive compensation advisory vote, but zero for the auditor ratification.

16-06-2026

Ingersoll Rand Inc. held its 2026 annual meeting on June 11, 2026, where stockholders approved all four proposals, including the election of ten directors, ratification of Deloitte & Touche as auditor, advisory approval of executive compensation, and the new 2026 Omnibus Incentive Plan. All director nominees received strong support, with the lowest 'For' vote percentage being 86.6% for William P. Donnelly, while the highest was 99.6% for Jerome Guillen and Marc E. Jones. The meeting had a high turnout of 95.3% of eligible shares.

• · The 2026 Omnibus Incentive Plan was approved with 353,964,877 For votes, 6,254,223 Against, and 299,541 Abstain.
• · Advisory vote on executive compensation passed with 350,614,090 For, 9,557,163 Against, and 347,388 Abstain.
• · Ratification of Deloitte & Touche as auditor for fiscal 2026 passed with 363,304,149 For, 9,594,166 Against, and 67,678 Abstain.
• · Broker non-votes totaled 12,447,352 on all director elections and on proposals 1, 3, and 4.
• · The meeting was held on June 11, 2026, with a record date of April 16, 2026.

16-06-2026

Elutia Inc. held its 2026 Annual Meeting of Stockholders on June 11, 2026, where stockholders approved all proposals, including the election of two Class III directors (David Colpman and Kevin Rakin), ratification of PricewaterhouseCoopers LLP as independent auditor, and the First Amendment to the 2020 Incentive Award Plan (adding 3,000,000 shares and extending the plan through 2036). The advisory say-on-pay vote was approved, and stockholders recommended an annual frequency for future advisory votes, which the Board adopted. The meeting had 34,041,545 shares represented (77.0% of outstanding shares).

• · Proposal 1 (Election of Directors): David Colpman received 25,384,500 FOR votes and 1,708,821 WITHHELD; Kevin Rakin received 26,902,953 FOR and 190,368 WITHHELD.
• · Proposal 2 (Ratification of Auditor): 33,866,728 FOR, 174,255 AGAINST, 562 ABSTAINED.
• · Proposal 3 (Incentive Plan Amendment): 22,421,769 FOR, 3,540,699 AGAINST, 1,130,851 ABSTAINED, with 6,948,226 broker non-votes.
• · Proposal 4 (Advisory Say-on-Pay): 25,617,864 FOR, 336,249 AGAINST, 1,139,206 ABSTAINED.
• · Proposal 5 (Frequency of Say-on-Pay): 20,932,402 voted for every 1 year, 1,849,469 for every 2 years, 4,161,721 for every 3 years, 149,728 abstained.
• · The Board of Directors determined to hold future advisory votes on executive compensation annually.

16-06-2026

Atlas Lithium Corporation increased compensation for CFO Tiago Miranda to $360,000 base salary plus a $120,000 annual bonus opportunity and $480,000 in RSUs. Separately, the company resolved a Brazilian civil action by N'Golo NGO regarding community consultation for its expansion permit, with a vote on the permit now scheduled for June 26, 2026.

• · CFO compensation increase is retroactive to May 29, 2026.
• · RSUs vest in 25% increments on July 23, 2026, 2027, 2028, and 2029.
• · Bonus is contingent on timely SEC periodic report filings.
• · Expansion permit vote scheduled for June

16-06-2026

PennyMac Mortgage Investment Trust (PMT-PC) announced the appointment of Scott Sauer to its Board of Trustees, effective June 16, 2026. Mr. Sauer brings over 30 years of financial sector experience, including nearly two decades as an audit partner at Deloitte & Touche LLP. The filing contains no financial results or period-over-period comparisons.

• · Scott Sauer is a licensed CPA and holds a Directorship Certification from the National Association of Corporate Directors (NACD.DC).
• · He earned a B.S. from the United States Military Academy at West Point and an MBA from Seattle University.
• · He serves as Chair of both the Audit and Compensation Committees and Vice-Chair of the Finance Committee at the West Point Association of Graduates.
• · PMT is externally managed by PNMAC Capital Management, LLC, a wholly-owned subsidiary of PennyMac Financial Services, Inc. (NYSE: PFSI).

16-06-2026

Tim Nixdorff, a non-executive director of Perfect Moment Ltd. (PMNT), resigned effective June 11, 2026, citing disagreements regarding the direction of the company. His resignation also terminates his roles on the Compensation Committee and the Nominating and Corporate Governance Committee. This departure highlights potential strategic discord within the board.

• · Tim Nixdorff resigned effective immediately on June 11, 2026.
• · Resignation covers board membership and committee roles (Compensation Committee, Nominating and Corporate Governance Committee).
• · Reason cited: 'apparent disagreements regarding the direction of the company'.
• · Nixdorff expressed hope the company 'can turn it around', implying concern about current performance.

16-06-2026

Imunon, Inc. (IMNN) held its 2026 Annual Meeting on June 16, 2026, where shareholders re-elected two Class I directors (Frederick J. Fritz and Christine A. Pellizzari), ratified the appointment of WithumSmith + Brown, PC as auditor, approved the advisory say-on-pay resolution, and approved an amendment to the 2018 Stock Incentive Plan that increases the share reserve by 1,000,000 shares to a total of 1,265,004 shares. All proposals passed, though say-on-pay and the share plan amendment received notable opposition (17.6% and 19.9% of votes cast against, respectively).

• · Class I director nominees were elected with ~90% of votes cast (excluding broker non-votes) – Frederick Fritz received 647,890 for vs. 70,401 withheld; Christine Pellizzari received 653,302 for vs. 64,989 withheld.
• · Amendment to the stock incentive plan passed with 562,622 for, 137,055 against, and 18,614 abstain – the 19.9% opposition represents significant shareholder dissent.
• · Ratification of WithumSmith + Brown, PC as auditor passed with 1,715,881 for, 81,399 against, and 11,386 abstain (including shares held by broker non-votes).
• · Advisory say-on-pay passed with 580,096 for, 115,666 against, 22,529 abstain – 17.6% opposition.
• · The effective date of the amendment to the 2018 Stock Incentive Plan is June 16, 2026.
• · The 8-K is signed by Susan Eylward in her capacity as General Counsel and Corporate Secretary.

16-06-2026

Rank One Computing Corp (ROC) appointed Dr. Kathleen Kiernan, a federal law enforcement veteran with three decades of experience, to its Board of Directors effective June 15, 2026. Following the appointment, the Board comprises eight directors, five of whom are independent. Dr. Kiernan's background in biometric identity, national security, and law enforcement is expected to support ROC's growth strategy and expansion of its Vision AI platform.

• · Dr. Kiernan previously served as President of NEC National Security Systems, helping federal customers with biometric identity, AI, machine learning, and computer vision solutions.
• · She served as Assistant Director for the Office of Strategic Intelligence and Information at the U.S. Bureau of Alcohol, Tobacco and Firearms (ATF).
• · Dr. Kiernan holds a Doctorate in Education from Northern Illinois University (with highest honors), an M.S. in Strategic Intelligence from the Joint Military Intelligence College, and an M.A. in International Transactions from George Mason University.
• · She is an adjunct faculty member at Johns Hopkins School of Education and the Center for Homeland Defense and Security at the Naval Postgraduate School.

16-06-2026

CRH elected W. Anthony (Tony) Will, former CEO of CF Industries, to its Board of Directors effective July 1, 2026. The appointment brings extensive industrial leadership and operational expertise to support CRH's strategy in modern infrastructure markets. No negative or flat performance metrics were disclosed in this filing.

• · Tony Will, age 60, will join the board effective July 1, 2026.
• · Will served as president, CEO and board member of CF Industries from 2014 until his retirement in 2026.
• · He currently serves as a Director of Union Pacific Corporation and was formerly a Director of Olin Corporation.
• · Will holds a bachelor's degree in electrical engineering from Iowa State University and an MBA from Northwestern University's Kellogg School of Management.
• · CRH has 83,000 employees across 4,000 locations and is a member of the S&P 500 Index.

16-06-2026

Shore Bancshares, Inc. announced the appointment of B. Scot Ebron as President of Shore United Bank, effective June 16, 2026, with Ebron also joining the Bank's Board of Directors. James M. Burke continues as CEO of the Bank and President and CEO of the holding company, while the filing reflects no material financial or operational changes.

16-06-2026

Capri Holdings Ltd announced that Director Stephen Reitman will not stand for re-election at the 2026 Annual Meeting of Shareholders, with his term ending on July 29, 2026. The retirement is not due to any disagreement with the company's operations, policies, or practices.

• · Mr. Reitman's term ends at the conclusion of the 2026 Annual Meeting on July 29, 2026.
• · The filing was made on June 16, 2026, reporting an event from June 11, 2026.

16-06-2026

Palvella Therapeutics held its 2026 Annual Meeting on June 10, 2026, where stockholders approved all six proposals, including the election of three Class III directors (George M. Jenkins, Todd C. Davis, and John Doux, M.D.), ratification of Ernst & Young as independent auditor, advisory approval of executive compensation, a preference for annual advisory votes on compensation, an amendment to the 2024 Equity Incentive Plan to increase authorized shares by 750,000, and an adjournment proposal that was not needed. The Plan Amendment became effective immediately upon stockholder approval.

• · Proposal 1 (Director Election): George M. Jenkins received 9,907,220 votes for, 268,834 withheld; Todd C. Davis received 8,321,303 for, 1,854,751 withheld; John Doux, M.D. received 9,958,528 for, 217,526 withheld. Broker non-votes: 1,401,415 for each.
• · Proposal 2 (Auditor Ratification): 11,557,687 for, 13,216 against, 6,566 abstentions.
• · Proposal 3 (Advisory Say-on-Pay): 10,008,180 for, 160,717 against, 7,157 abstentions, 1,401,415 broker non-votes.
• · Proposal 4 (Frequency of Say-on-Pay): 9,183,170 for every year, 1,002 for every 2 years, 984,332 for every 3 years, 7,550 abstain, 1,401,415 broker non-votes. Board determined to hold annual advisory votes.
• · Proposal 5 (Plan Amendment): 7,692,709 for, 2,475,470 against, 7,875 abstentions, 1,401,415 broker non-votes.
• · Proposal 6 (Adjournment): 7,649,243 for, 2,519,068 against, 7,743 abstentions, 1,401,415 broker non-votes.

16-06-2026

Cincinnati Financial Corporation announced the retirement of John S. Kellington, chief information officer and executive vice president of its lead subsidiary, effective August 7, 2026. Ryan M. Osborn, vice president of Information Technology, will assume executive responsibility for IT teams. The company emphasized a smooth transition through established succession planning processes.

• · Kellington joined the company in 2010 and transformed IT operations by championing an architecture-led IT model.
• · Osborn joined in 2000 and has played key roles in maturing the architecture program, reducing technical debt, and accelerating modernization through Agile and DevOps.
• · The company's succession planning process is designed to ensure smooth transitions for key leaders.

16-06-2026

Corvex (formerly Movano Inc., Nasdaq: MOVE) announced the appointment of Christopher Chance Moreland as Chief Financial Officer, effective June 29, 2026. Moreland, a Morgan Stanley Managing Director with over 12 years of experience in leveraged and acquisition finance, will lead capital formation to support the company's AI infrastructure expansion. The appointment reflects Corvex's focus on building institutional-grade financial capabilities for its GPU-accelerated AI cloud platform.

• · Moreland holds an MBA from Columbia Business School, a Master of Science in Aeronautics and Astronautics from Stanford University, and dual degrees in Economics and Physics-Engineering from Washington and Lee University.
• · He is a CFA charterholder.
• · Corvex's model combines contracted demand, flexible access to power, proprietary software, and disciplined capital formation.
• · The company focuses on GPU-accelerated compute clusters, high-throughput storage systems, and layered architecture.

16-06-2026

M&T Bank Corporation elected Jerry Jacobs Jr., CEO of Delaware North, to its Board of Directors effective June 16, 2026. The appointment adds an executive with deep hospitality leadership experience and strong ties to Western New York. No financial terms or changes to officers were disclosed in this pure governance disclosure.

• · Jerry Jacobs Jr. has held senior leadership roles at Delaware North since 1986 and was named CEO in 2015.
• · He shares the CEO title with his brothers Lou and Charlie Jacobs.
• · Jacobs serves as chair of the UB Council and is a member of the US Travel Association CEO Roundtable.
• · No financial compensation or terms of the board appointment were disclosed in the filing.
• · The appointment did not involve any departure of existing directors or officers under Item 5.02.

16-06-2026

Madison Air Solutions Corp appointed David M. Wisniewski as Chief Accounting Officer, effective June 17, 2026, with an annual base salary of $355,000, target annual incentive of 50% of base salary, and an equity award of approximately $700,000. Michael Kenning will revert to Global Controller. No negative or flat metrics are present.

• · David Wisniewski, age 57, previously VP and CAO at James Hardie Industries (Apr 2024-Mar 2026) and SVP and CAO at Gates Industrial (Apr 2018-Apr 2024).
• · Wisniewski holds a BBA from University of Michigan and is a CPA in Michigan.
• · Equity award vests on July 15, 2031.
• · No family relationships or related person transactions with the company.